H-1B sponsorship profile: Stelexis Therapeutics, LLC. Across U.S. Department of Labor LCA disclosures, Stelexis Therapeutics, LLC filed 1 Labor Condition Applications covering 1 H-1B worker positions between fiscal year 2023 and fiscal year 2023. The employer’s DOL certification rate sits at 100% (1 certified of 1 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Stelexis Therapeutics, LLC’s H-1B petitions range from $131,726 at the low end to $131,726 at the high end, with a petition-weighted average of $131,726. That range reflects the mix of occupations the company sponsors, led by Associate Director – Platform Development (1 petitions at $131,726 avg). H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Stelexis Therapeutics, LLC is headquartered in Bronx, NY under NAICS code 541714, and places H-1B workers across 1 state, most heavily in NY. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Stelexis Therapeutics, LLC ranks. By H-1B petition volume, Stelexis Therapeutics, LLC is #72,571 of 119,880 employers nationally and #8,544 of 14,719 employers headquartered in NY. Both ranks are computed live from the same underlying petition counts, not a separate estimate.